北美循环肿瘤细胞 (CTC) 诊断市场预测至 2028 年 - COVID-19 影响和区域技术分析（CTC 检测和富集方法、CTC 直接检测方法和 CTC 分析）、应用（临床/液体活检和研究）和最终用户（医院和诊所、研究和学术机构以及诊断中心）
No. of Pages: 130 | Report Code: TIPRE00028650 | Category: Life Sciences
No. of Pages: 130 | Report Code: TIPRE00028650 | Category: Life Sciences
该地区的卫生系统的癌症患病率大幅上升。根据国际癌症研究机构 (IARC) 的数据，截至 2020 年，北美癌症负担已增至 1,930 万例，癌症死亡人数为 996 万。美国国家癌症研究所发表的一项研究估计，美国癌症发病率为 1.9到 2021 年，美国将有约 60 万人死于癌症。因此，北美地区癌症患病率的上升推动了对循环肿瘤细胞 (CTC) 诊断的需求。循环肿瘤细胞的分析和检测有助于患者的早期诊断，预后有助于为患者确定准确的治疗方案。 CTC 诊断可用于检测各种类型的癌症，包括前列腺癌、乳腺癌、结直肠癌、肾癌、淋巴瘤、肺癌和黑色素瘤。近年来，由于 CTC 诊断在识别疾病风险和监测治疗方面的可靠性和准确性，对 CTC 诊断的需求很高。
COVID-19 大流行对癌症患者、癌症监测能力以及整个美国卫生系统的影响非常显着。资源减少和医疗保健能力有限使得癌症检测和治疗变得更加困难，从而导致未来发病率降低、死亡率升高和生存率降低。由于癌症和/或其治疗（例如手术和化疗）导致免疫系统受损，患有活动性癌症的人更容易受到传染性病原体的影响。因此，癌症患者中 COVID-19 严重程度和死亡的风险可能更常见。男性； 60岁及以上的人；有吸烟史的人；患有肥胖、高血压、心血管疾病和糖尿病的人群一直与严重疾病和/或死亡风险升高相关。事实证明，与癌症相关变量的预后相关的研究结果是相互矛盾的。
借助新功能和技术，供应商可以吸引新客户并扩大其业务范围新兴市场的足迹。这一因素可能会在预测期内推动北美循环肿瘤细胞 (CTC) 诊断市场实现良好的复合年增长率。
北美循环肿瘤细胞 (CTC) 诊断市场细分
Strategic insights for North America Circulating Tumor Cell (CTC) Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 861.6 Million |
| Market Size by 2028 | US$ 1,664.0 Million |
| Global CAGR (2021 - 2028) | 9.9% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 技术
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Circulating Tumor Cell (CTC) Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Circulating Tumor Cell (CTC) Diagnostics Market is valued at US$ 861.6 Million in 2021, it is projected to reach US$ 1,664.0 Million by 2028.
As per our report North America Circulating Tumor Cell (CTC) Diagnostics Market, the market size is valued at US$ 861.6 Million in 2021, projecting it to reach US$ 1,664.0 Million by 2028. This translates to a CAGR of approximately 9.9% during the forecast period.
The North America Circulating Tumor Cell (CTC) Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Circulating Tumor Cell (CTC) Diagnostics Market report:
The North America Circulating Tumor Cell (CTC) Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Circulating Tumor Cell (CTC) Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Circulating Tumor Cell (CTC) Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Circulating Tumor Cell (CTC) Diagnostics Market
